Double-blind study of the effect of selective serotonin reuptake inhabitor fluvoxamine on cognitive deficits in schizophrenia.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2012
At a glance
- Drugs Fluvoxamine (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- 08 Jun 2011 Status changed from active, no longer recruiting to completed.
- 04 Feb 2010 New trial record